Berallo, Antonio, .
HRN: 04-06-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/25/2025
05/31/2025
IV
1.5gm
Q6
Pleural Effusion Sec To PTB Vs CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes